6 types of cancer can be treated with immunotherapy

The immune therapy uses the body’s immune system to identify and destroy cancer cells. Master, Doctor Nguyen The Thu, Department of Oncology, Tam Anh General Hospital in Hanoi, said this therapy opened hope for cancer people, especially when traditional methods such as surgery, chemotherapy, radiation did not achieve the desired effect. However, the effectiveness of immunotherapy is not heterogeneous for all types of cancer. Here are some effective cancer that responds well to immunotherapy.

Lung cancer

According to the collection, lung cancer, especially non -small cell lung cancer (NSCLC), shows a positive response to immunotherapy. The drug contains immune control inhibitors such as PembroLizumab and Nivolumab, Durvalumab approved for supplementary treatment (treatment of destruction of cancer cells, disease control), progressive stage, distant metastasis for patients with appropriate tests. The drug works to prevent proteins on the surface of cancer cells, helping the immune system to identify and attack more effectively.

Colorectal cancer

Traditional colorectal cancer treatments such as chemotherapy, radiation and surgery. Recently, immunotherapy has been applied in the treatment of colorectal cancer, taking advantage of the patient’s immune system to help kill cancer cells. A number of immune therapy options are approved by the US Food and Drug Administration (FDA) (FDA) to treat colon cancer treatment including tumors with microsatellite instability high (MSI -H) or DNA (Deficient Miscatch Repair (DMMR).

Currently, the system of Tam Anh General Hospital coordinates with scientists of the Stanford Microbiology and Anti -Institute of Research in the United States to conduct the clinical trial of oral immunogen to treat RBS2418 cancer, in the immediate future, test on colorectal cancer.

Breast cancer

Breast cancer at an early stage can be treated with surgery. Depending on the stage and molecular characteristics of cancer when diagnosed, your doctor may use it alone or combine methods such as chemotherapy, hormonal therapy, surgery, radiation. The doctor chooses immunotherapy depending on the type of tumor of the patient.

Bladder cancer

Traditional bladder cancer treatments such as surgery and chemotherapy. Dr. Thu said in recent years, immunotherapy has become an important part of the treatment regimen. This therapy helps reduce the risk of recurrence of bladder cancer, while increasing the proportion of patients with complete response after surgery.

Kidney cancer

Kidney cell carcinoma responds well to immunotherapy. Interleukin-2 (IL-2) is a type of cytokine used to stimulate the immune system to attack kidney cancer cells. Recently, drugs containing immune control inhibitors such as Nivolumab, Pembrolizumab have also been approved for advanced renal cancer treatment.

Head and neck cancer

Head and neck cancer include many types such as throat, larynx, oral cavity. Immunotherapy, especially the type that contains PD-1 inhibitors such as PembroLizumab, Nivolumab, can benefit patients with head and neck cancer patients recurrent or metastatic. These drugs help enhance immune response against cancer cells, improve treatment results.

Immunotherapy is effective in cancer treatment. “This is a new method, the cost of treatment is quite high and has not been paid by the health insurance,” said Dr. Thu, adding that Tam Anh General Hospital is implementing price subsidy programs for patients treated with immunotherapy. Specifically, the patient buys a dosage to get one dose, buy two doses to get one dose, contributing to reducing costs.